Identification of a new insertion in exon 20 of EGFR in a woman with NSCLC.

about

A novel insertion mutation on exon 20 of epidermal growth factor receptor, conferring resistance to erlotinib.

P2860

Q34131441-0181AFFF-3B25-46CF-B7A5-A12F7BFEFE5D

P2860

Identification of a new insertion in exon 20 of EGFR in a woman with NSCLC.

Item

http://www.wikidata.org/entity/Q51326919

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Identification of a new insertion in exon 20 of EGFR in a woman with NSCLC.

@en

Identification of a new insertion in exon 20 of EGFR in a woman with NSCLC.

@nl

type

Item

label

Identification of a new insertion in exon 20 of EGFR in a woman with NSCLC.

@en

Identification of a new insertion in exon 20 of EGFR in a woman with NSCLC.

@nl

prefLabel

Identification of a new insertion in exon 20 of EGFR in a woman with NSCLC.

@en

Identification of a new insertion in exon 20 of EGFR in a woman with NSCLC.

@nl

P1476

Identification of a new insertion in exon 20 of EGFR in a woman with NSCLC.

@en

P2093

Alfredo Tartarone

http://www.w3.org/2001/XMLSchema#string

Angela Zupa

http://www.w3.org/2001/XMLSchema#string

Giulia Vita

http://www.w3.org/2001/XMLSchema#string

Giuseppina Improta

http://www.w3.org/2001/XMLSchema#string

Luciana Possidente

http://www.w3.org/2001/XMLSchema#string

Michele Aieta

http://www.w3.org/2001/XMLSchema#string

P2860

The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP

Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain

Structures of Lung Cancer-Derived EGFR Mutants and Inhibitor Complexes: Mechanism of Activation and Insights into Differential Inhibitor Sensitivity

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors

Epidermal growth factor receptor mutations in lung cancer

Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors

Structural and mechanistic underpinnings of the differential drug sensitivity of EGFR mutations in non-small cell lung cancer.

EGFR exon 20 insertion mutations in non-small-cell lung cancer: preclinical data and clinical implications.

P2888

s12032-012-0304-y

P304

3198-3201

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-012-0304-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Matteo Landriscina

P577

2012-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

228445470

http://www.w3.org/2001/XMLSchema#string

P698

22773041

http://www.w3.org/2001/XMLSchema#string

Identification of a new insertion in exon 20 of EGFR in a woman with NSCLC.

about

P2860

P2860

Identification of a new insertion in exon 20 of EGFR in a woman with NSCLC.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698